Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.

Eitemau Tebyg

• T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
  gan: Hale, G, et al.
  Cyhoeddwyd: (1988)
• Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
  gan: Apperley, J, et al.
  Cyhoeddwyd: (1986)
• Availability of Campath-1 antibodies for bone marrow transplantation.
  gan: Hale, G, et al.
  Cyhoeddwyd: (1995)
• CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
  gan: Hale, G, et al.
  Cyhoeddwyd: (1994)
• Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
  gan: Waldmann, H, et al.
  Cyhoeddwyd: (1985)